Open access
Aug 2026
CARS1 as a Prognostic Biomarker and Candidate Therapeutic Vulnerability in Hepatocellular Carcinoma: Insights Into Tumor Progression and the Immune Microenvironment.
Clinical, histopathological, and loss-of-function findings support further investigation of CARS1 as a prognostic marker and candidate therapeutic target in HCC, although additional mechanistic and in vivo validation is required.
Ye-Zhen Tang, Ke-Jun Liu, Zhen-Ya Tan et al.
· Frontiers in Bioscience · 0 citations